- Cellcom Israel‘s net income for the second quarter increased by 16%, reaching 64 million shekels, compared to 55 million shekels in the same period last year.
- The company’s revenue decreased by 4.8%, amounting to 1.05 billion shekels.
- There was a decline of 6.7% in mobile average revenue per user, which is now 41.80 shekels.
- Cellcom Israel‘s shares rose by 3.1%, reaching a price of 3,009 Israeli shekels, with a volume of 43,938 shares traded.
- Analyst recommendations for the stock include 1 buy rating, no hold ratings, and 2 sell ratings.
A look at Cellcom Israel Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 1 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Cellcom Israel, a cellular communications services provider, shows a promising long-term outlook according to the Smartkarma Smart Scores. With strong scores in Growth and Momentum factors, the company is positioned well for future expansion and market performance. The high growth score indicates potential for increasing revenue and market share, while momentum suggests a positive trend in the stock price. Although the Dividend score is lower, the overall outlook remains positive due to the favorable scores in other key areas.
As a company with operations in both cellular services and landline telephony, Cellcom Israel has a diversified business model. With its subsidiary Netvision, the company offers a range of services including internet, roaming, and messaging. The company’s focus on resilience and value, reflected in the Smart Scores, further reinforces its stability in the market. Overall, Cellcom Israel‘s strategic positioning and strong scores in Growth and Momentum indicate a bright future ahead, supported by a solid foundation in the telecommunications industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
